CHINA PHARMA HOLDINGS, INC. Accounts Receivable, Credit Loss Expense (Reversal)
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Accounts Receivable, Credit Loss Expense (Reversal) of $5.54 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. accounts receivable, credit loss expense (reversal) for the quarter ending 2026-06-30 was $5.54K, a 172.54% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. accounts receivable, credit loss expense (reversal) for the quarter ending 2026-03-31 was -$2.88K.
- CHINA PHARMA HOLDINGS, INC. accounts receivable, credit loss expense (reversal) for the quarter ending 2025-12-31 was -$27.03K, a 2951.16% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. accounts receivable, credit loss expense (reversal) for the quarter ending 2025-09-30 was $25.30K.
- CHINA PHARMA HOLDINGS, INC. accounts receivable, credit loss expense (reversal) for fiscal 2025 was -$1.02K, a 117.85% decline from fiscal 2024.
- CHINA PHARMA HOLDINGS, INC. accounts receivable, credit loss expense (reversal) for fiscal 2024 was $5.70K.
- CHINA PHARMA HOLDINGS, INC. accounts receivable, credit loss expense (reversal) for fiscal 2023 was -$15.76K.
- CHINA PHARMA HOLDINGS, INC. accounts receivable, credit loss expense (reversal) for fiscal 2022 was -$93.85K.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 3 month | Accounts Receivable, Credit Loss Expense (Reversal) 3 month as first filed | Accounts Receivable, Credit Loss Expense (Reversal) 6 month | Accounts Receivable, Credit Loss Expense (Reversal) 6 month as first filed | Accounts Receivable, Credit Loss Expense (Reversal) 9 month | Accounts Receivable, Credit Loss Expense (Reversal) 9 month as first filed | Accounts Receivable, Credit Loss Expense (Reversal) 12 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.54K 10-Q · filed 2026-08-14 | $2.66K 10-Q · filed 2026-08-14 | -$24.37K derived: sum of 3 quarters · filed 2026-08-14 | $930.00 derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | -$2.88K 10-Q · filed 2026-05-15 | -$29.91K derived: sum of 2 quarters · filed 2026-05-15 | -$4.61K derived: sum of 3 quarters · filed 2026-05-15 | -$2.58K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$27.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$1.73K derived: sum of 2 quarters · filed 2026-04-01 | $305.00 derived: sum of 3 quarters · filed 2026-08-14 | -$1.02K 10-K · filed 2026-04-01 | ||||
| 2025-09-30 | $25.30K 10-Q · filed 2025-11-12 | $27.33K derived: sum of 2 quarters · filed 2026-08-14 | $26.01K 10-Q · filed 2025-11-12 | $26.96K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $2.03K 10-Q · filed 2026-08-14 | $709.00 10-Q · filed 2026-08-14 | $1.66K derived: sum of 3 quarters · filed 2026-08-14 | $1.00 derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | -$1.32K 10-Q · filed 2026-05-15 | -$375.00 derived: sum of 2 quarters · filed 2026-05-15 | -$2.03K derived: sum of 3 quarters · filed 2026-05-15 | $6.45K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $948.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$708.00 derived: sum of 2 quarters · filed 2026-04-01 | $7.77K derived: sum of 3 quarters · filed 2026-04-01 | $5.70K 10-K · filed 2026-04-01 | ||||
| 2024-09-30 | -$1.66K 10-Q · filed 2025-11-12 | $6.82K derived: sum of 2 quarters · filed 2025-11-12 | $4.75K 10-Q · filed 2025-11-12 | $13.20K derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $8.48K 10-Q · filed 2025-08-14 | $6.41K 10-Q · filed 2025-08-14 | $14.85K derived: sum of 3 quarters · filed 2025-08-14 | -$3.36K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$2.07K 10-Q · filed 2025-05-14 | $6.38K derived: sum of 2 quarters · filed 2025-05-14 | -$11.83K derived: sum of 3 quarters · filed 2025-05-14 | -$7.79K derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $8.44K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$9.77K derived: sum of 2 quarters · filed 2025-03-31 | -$5.72K derived: sum of 3 quarters · filed 2025-03-31 | -$15.76K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$18.21K 10-Q · filed 2024-11-13 | -$14.16K derived: sum of 2 quarters · filed 2024-11-13 | -$24.20K 10-Q · filed 2024-11-13 | -$34.34K derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $4.05K 10-Q · filed 2024-08-14 | -$5.99K 10-Q · filed 2024-08-14 | -$16.13K derived: sum of 3 quarters · filed 2024-08-14 | -$89.96K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$10.04K 10-Q · filed 2023-05-12 | -$20.17K derived: sum of 2 quarters · filed 2024-04-01 | -$94.01K derived: sum of 3 quarters · filed 2024-04-01 | -$98.37K derived: sum of 4 quarters · filed 2024-04-01 | ||||
| 2022-12-31 | -$10.14K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$83.97K derived: sum of 2 quarters · filed 2024-04-01 | -$88.33K derived: sum of 3 quarters · filed 2024-04-01 | -$93.85K 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | -$73.84K 10-Q · filed 2023-11-13 | -$78.19K derived: sum of 2 quarters · filed 2023-11-13 | -$83.72K 10-Q · filed 2023-11-13 | -$334.34K derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | -$4.36K 10-Q · filed 2023-08-14 | -$9.88K 10-Q · filed 2023-08-14 | -$260.50K derived: sum of 3 quarters · filed 2023-08-14 | -$252.13K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$5.52K 10-Q · filed 2023-05-12 | -$256.14K derived: sum of 2 quarters · filed 2023-05-12 | -$247.77K derived: sum of 3 quarters · filed 2023-05-12 | -$252.51K derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | -$250.62K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$242.25K derived: sum of 2 quarters · filed 2023-03-30 | -$246.99K derived: sum of 3 quarters · filed 2023-03-30 | -$255.22K 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $8.37K 10-Q · filed 2022-11-14 | $3.63K derived: sum of 2 quarters · filed 2022-11-14 | -$4.59K 10-Q · filed 2022-11-14 | $68.28K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$4.74K 10-Q · filed 2022-08-11 | -$12.96K 10-Q · filed 2022-08-11 | $59.91K derived: sum of 3 quarters · filed 2022-08-11 | $77.29K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$8.22K 10-Q · filed 2022-05-12 | $64.65K derived: sum of 2 quarters · filed 2022-05-12 | $82.04K derived: sum of 3 quarters · filed 2022-05-12 | $76.72K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $72.87K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $90.26K derived: sum of 2 quarters · filed 2022-03-30 | $84.94K derived: sum of 3 quarters · filed 2022-03-30 | $115.19K 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $17.39K 10-Q · filed 2021-11-12 | $12.07K derived: sum of 2 quarters · filed 2021-11-12 | $42.31K 10-Q · filed 2021-11-12 | -$9.24K derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | -$5.32K 10-Q · filed 2021-08-13 | $24.93K 10-Q · filed 2021-08-13 | -$26.63K derived: sum of 3 quarters · filed 2021-08-13 | $4.68K derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $30.25K 10-Q · filed 2021-05-14 | -$21.31K derived: sum of 2 quarters · filed 2021-05-14 | $9.99K derived: sum of 3 quarters · filed 2021-05-14 | $20.09K derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | -$51.55K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | -$20.25K derived: sum of 2 quarters · filed 2021-03-26 | -$10.16K derived: sum of 3 quarters · filed 2021-03-26 | $3.15K 10-K · filed 2021-03-26 | ||||
| 2019-09-30 | $31.30K 10-Q · filed 2020-11-13 | $41.40K derived: sum of 2 quarters · filed 2020-11-13 | $54.71K 10-Q · filed 2020-11-13 | -$822.69K derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $10.09K 10-Q · filed 2020-08-13 | $23.40K 10-Q · filed 2020-08-13 | -$853.99K derived: sum of 3 quarters · filed 2020-08-13 | $275.11K derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $13.31K 10-Q · filed 2020-05-14 | -$864.09K derived: sum of 2 quarters · filed 2020-05-14 | $265.02K derived: sum of 3 quarters · filed 2020-05-14 | $615.87K derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | -$877.40K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $251.71K derived: sum of 2 quarters · filed 2020-03-30 | $602.55K derived: sum of 3 quarters · filed 2020-03-30 | $604.39K 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | $1.13M 10-Q · filed 2019-11-14 | $1.48M derived: sum of 2 quarters · filed 2019-11-14 | $1.48M 10-Q · filed 2019-11-14 | $1.92M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $350.85K 10-Q · filed 2019-08-14 | $352.68K 10-Q · filed 2019-08-14 | $791.74K derived: sum of 3 quarters · filed 2019-08-14 | $1.02M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $1.83K 10-Q · filed 2019-05-14 | $440.89K derived: sum of 2 quarters · filed 2019-05-14 | $670.36K derived: sum of 3 quarters · filed 2019-05-14 | $1.04M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $439.06K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $668.52K derived: sum of 2 quarters · filed 2019-03-28 | $1.03M derived: sum of 3 quarters · filed 2019-03-28 | $1.39M 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | $229.47K 10-Q · filed 2018-11-14 | $594.46K derived: sum of 2 quarters · filed 2018-11-14 | $954.52K 10-Q · filed 2018-11-14 | $1.04M derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | $364.99K 10-Q · filed 2018-08-14 | $725.05K 10-Q · filed 2018-08-14 | $805.55K derived: sum of 3 quarters · filed 2018-08-14 | $735.65K derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | $360.06K 10-Q · filed 2018-05-14 | $440.56K derived: sum of 2 quarters · filed 2018-05-14 | $370.66K derived: sum of 3 quarters · filed 2018-05-14 | $865.21K derived: sum of 4 quarters · filed 2018-05-14 | ||||
| 2016-12-31 | $80.50K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $10.60K derived: sum of 2 quarters · filed 2018-04-02 | $505.15K derived: sum of 3 quarters · filed 2018-04-02 | $1.09M 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | -$69.90K 10-Q · filed 2017-11-14 | $424.65K derived: sum of 2 quarters · filed 2017-11-14 | $1.01M 10-Q · filed 2017-11-14 | $5.11M derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | $494.55K 10-Q · filed 2017-08-14 | $1.08M 10-Q · filed 2017-08-14 | $5.18M derived: sum of 3 quarters · filed 2017-08-14 | $2.02M derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | $581.30K 10-Q · filed 2017-05-11 | $4.68M derived: sum of 2 quarters · filed 2017-05-11 | $1.52M derived: sum of 3 quarters · filed 2017-05-11 | -$1.62M derived: sum of 4 quarters · filed 2017-05-11 | ||||
| 2015-12-31 | $4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $941.08K derived: sum of 2 quarters · filed 2017-03-31 | -$2.20M derived: sum of 3 quarters · filed 2017-03-31 | $10.15M 10-K · filed 2017-03-31 | ||||
| 2015-09-30 | -$3.16M 10-Q · filed 2016-11-14 | $3.92M 10-Q · filed 2015-11-16 | -$6.30M derived: sum of 2 quarters · filed 2016-11-14 | $6.05M 10-Q · filed 2016-11-14 | $13.13M 10-Q · filed 2015-11-16 | $12.97M derived: sum of 4 quarters · filed 2016-11-14 | ||
| 2015-06-30 | -$3.14M 10-Q · filed 2016-08-11 | $2.10M 10-Q · filed 2015-08-14 | $3.96M 10-Q · filed 2016-08-11 | $9.21M 10-Q · filed 2015-08-14 | $16.13M derived: sum of 3 quarters · filed 2016-08-11 | $20.07M derived: sum of 4 quarters · filed 2016-08-11 | ||
| 2015-03-31 | $3.20M 10-Q · filed 2016-05-16 | $7.10M 10-Q · filed 2015-05-11 | $19.27M derived: sum of 2 quarters · filed 2016-05-16 | $23.21M derived: sum of 3 quarters · filed 2016-05-16 | $31.24M derived: sum of 4 quarters · filed 2016-05-16 | |||
| 2014-12-31 | $16.07M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $20.01M derived: sum of 2 quarters · filed 2016-03-30 | $28.04M derived: sum of 3 quarters · filed 2016-03-30 | $31.35M 10-K · filed 2016-03-30 | $20.64M 10-K · filed 2015-03-30 | |||
| 2014-09-30 | $3.94M 10-Q · filed 2015-12-28 | $11.97M derived: sum of 2 quarters · filed 2015-12-28 | $15.28M 10-Q · filed 2015-12-28 | $18.12M derived: sum of 4 quarters · filed 2015-12-28 | ||||
| 2014-06-30 | $8.03M 10-Q · filed 2015-12-28 | $11.34M 10-Q · filed 2015-12-28 | $14.18M derived: sum of 3 quarters · filed 2015-12-28 | $17.46M derived: sum of 4 quarters · filed 2015-12-28 | ||||
| 2014-03-31 | $3.31M 10-Q · filed 2015-12-28 | $6.15M derived: sum of 2 quarters · filed 2015-12-28 | $9.43M derived: sum of 3 quarters · filed 2015-12-28 | $14.18M derived: sum of 4 quarters · filed 2015-12-28 | ||||
| 2013-12-31 | $2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-28 | $6.12M derived: sum of 2 quarters · filed 2015-12-28 | $10.87M derived: sum of 3 quarters · filed 2015-12-28 | $10.75M 10-K · filed 2015-12-28 | ||||
| 2013-09-30 | $3.28M 10-Q · filed 2014-11-14 | $8.03M derived: sum of 2 quarters · filed 2014-11-14 | $7.91M 10-Q · filed 2014-11-14 | $8.06M derived: sum of 4 quarters · filed 2014-11-14 | ||||
| 2013-06-30 | $4.75M 10-Q · filed 2014-08-14 | $4.63M 10-Q · filed 2014-08-14 | $4.78M derived: sum of 3 quarters · filed 2014-08-14 | $4.95M derived: sum of 4 quarters · filed 2014-08-14 | ||||
| 2013-03-31 | -$119.93K 10-Q · filed 2014-05-15 | $26.94K derived: sum of 2 quarters · filed 2014-05-15 | $198.44K derived: sum of 3 quarters · filed 2014-05-15 | $431.58K derived: sum of 4 quarters · filed 2014-05-15 | ||||
| 2012-12-31 | $146.87K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $318.38K derived: sum of 2 quarters · filed 2014-03-20 | $551.51K derived: sum of 3 quarters · filed 2014-03-20 | $871.61K 10-K · filed 2014-03-20 | ||||
| 2012-09-30 | $171.51K 10-Q · filed 2013-11-14 | $404.65K derived: sum of 2 quarters · filed 2013-11-14 | $724.75K 10-Q · filed 2013-11-14 | $1.02M derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2012-06-30 | $233.14K 10-Q · filed 2013-08-14 | $553.24K 10-Q · filed 2013-08-14 | $846.78K derived: sum of 3 quarters · filed 2013-08-14 | $770.60K derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | $320.10K 10-Q · filed 2013-05-14 | $613.65K derived: sum of 2 quarters · filed 2013-05-14 | $537.46K derived: sum of 3 quarters · filed 2013-05-14 | $418.75K derived: sum of 4 quarters · filed 2013-05-14 | ||||
| 2011-12-31 | $293.55K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $217.36K derived: sum of 2 quarters · filed 2013-03-14 | $98.66K derived: sum of 3 quarters · filed 2013-03-14 | $108.08K 10-K · filed 2013-03-14 | ||||
| 2011-09-30 | -$76.19K 10-Q · filed 2012-11-14 | -$194.89K derived: sum of 2 quarters · filed 2012-11-14 | -$185.46K 10-Q · filed 2012-11-14 | $104.05K derived: sum of 4 quarters · filed 2012-11-14 | ||||
| 2011-06-30 | -$118.70K 10-Q · filed 2012-08-14 | -$109.28K 10-Q · filed 2012-08-14 | $180.24K derived: sum of 3 quarters · filed 2012-08-14 | $287.43K derived: sum of 4 quarters · filed 2012-08-14 | ||||
| 2011-03-31 | $9.43K 10-Q · filed 2012-05-14 | $298.94K derived: sum of 2 quarters · filed 2012-05-14 | $406.13K derived: sum of 3 quarters · filed 2012-05-14 | $443.75K derived: sum of 4 quarters · filed 2012-05-14 | ||||
| 2010-12-31 | $289.52K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | $396.70K derived: sum of 2 quarters · filed 2012-03-14 | $434.32K derived: sum of 3 quarters · filed 2012-03-14 | $505.22K 10-K · filed 2012-03-14 | ||||
| 2010-09-30 | $107.19K 10-Q/A · filed 2012-03-06 | $144.80K derived: sum of 2 quarters · filed 2012-03-06 | $215.71K 10-Q/A · filed 2012-03-06 | |||||
| 2010-06-30 | $37.62K 10-Q/A · filed 2011-09-06 | $108.52K 10-Q/A · filed 2011-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |